Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 8,500 shares at $9.66 ($81K) on 2018-11-23, disclosed to the SEC on 2018-11-26.
Scheduled sale ($81k) by Senior Vice President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.41 | 5,000 | $47K | 58.2% |
| 2 | $9.66 | 3,500 | $34K | 41.8% |
| Total | $9.51 avg | 8,500 | $81K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |